Insulet Historical Financial Ratios
| PODD Stock | USD 268.32 2.93 1.10% |
Insulet is lately reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 18.15, Free Cash Flow Yield of 0.0175, Invested Capital of 0.0 or Operating Cash Flow Per Share of 6.45 will help investors to properly organize and evaluate Insulet financial condition quickly.
Insulet |
About Insulet Financial Ratios Analysis
InsuletFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Insulet investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Insulet financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Insulet history.
Insulet Financial Ratios Chart
Add Fundamental
Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Free Cash Flow Per Share
The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from Insulet's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Insulet current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.At present, Insulet's PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 73.44, whereas EV To Sales is forecasted to decline to 7.99.
| 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 16.22 | 27.98 | 31.61 | 33.19 | Days Of Inventory On Hand | 253.32 | 273.55 | 250.99 | 263.54 |
Insulet fundamentals Correlations
Click cells to compare fundamentals
Insulet Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Insulet fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 18.3 | 16.39 | 15.65 | 8.92 | 8.83 | 15.81 | |
| Ptb Ratio | 27.42 | 32.38 | 42.87 | 20.66 | 15.1 | 19.9 | |
| Days Sales Outstanding | 40.94 | 33.82 | 53.48 | 77.36 | 64.4 | 73.44 | |
| Book Value Per Share | 9.32 | 8.22 | 6.87 | 10.5 | 17.29 | 18.15 | |
| Free Cash Flow Yield | (0.004985) | (0.0106) | (0.001875) | 0.002412 | 0.0167 | 0.0175 | |
| Operating Cash Flow Per Share | 1.3 | (1.01) | 1.72 | 2.09 | 6.14 | 6.45 | |
| Stock Based Compensation To Revenue | 0.0389 | 0.0397 | 0.0313 | 0.0285 | 0.0335 | 0.0627 | |
| Capex To Depreciation | 3.01 | 2.14 | 2.49 | 1.04 | 1.55 | 1.47 | |
| Pb Ratio | 27.42 | 32.38 | 42.87 | 20.66 | 15.1 | 19.9 | |
| Ev To Sales | 18.4 | 16.81 | 16.2 | 9.34 | 8.41 | 7.99 | |
| Free Cash Flow Per Share | (1.27) | (2.82) | (0.55) | 0.52 | 4.36 | 4.58 | |
| Roic | (2.5E-4) | 0.0296 | (0.006548) | 0.0967 | 0.16 | 0.17 | |
| Inventory Turnover | 2.09 | 1.14 | 1.44 | 1.33 | 1.45 | 1.38 | |
| Net Income Per Share | 0.11 | 0.25 | 0.0663 | 2.96 | 5.97 | 6.27 | |
| Days Of Inventory On Hand | 174.85 | 319.2 | 253.32 | 273.55 | 250.99 | 263.54 | |
| Payables Turnover | 5.95 | 9.2 | 16.22 | 27.98 | 31.61 | 33.19 | |
| Capex To Revenue | 0.23 | 0.18 | 0.11 | 0.12 | 0.0445 | 0.0573 | |
| Cash Per Share | 15.26 | 11.69 | 10.46 | 10.48 | 13.61 | 18.89 | |
| Pocfratio | 197.0 | (264.5) | 171.62 | 103.87 | 42.52 | 50.5 | |
| Interest Coverage | 0.82 | (0.0133) | 1.09 | 6.08 | 7.23 | 7.6 | |
| Capex To Operating Cash Flow | 1.98 | (1.8) | 1.32 | 0.52 | 0.29 | 0.46 | |
| Pfcf Ratio | (200.58) | (94.4) | (533.25) | 414.65 | 59.9 | 62.9 | |
| Days Payables Outstanding | 61.31 | 39.69 | 22.5 | 13.05 | 11.55 | 10.97 | |
| Income Quality | 12.35 | (4.05) | 25.87 | 0.71 | 1.03 | 0.98 | |
| Roe | 0.0113 | 0.0302 | 0.009656 | 0.28 | 0.35 | 0.36 | |
| Ev To Operating Cash Flow | 198.15 | (271.21) | 177.73 | 108.76 | 40.5 | 51.04 | |
| Pe Ratio | 2.4K | 1.1K | 4.4K | 73.36 | 43.74 | 41.55 | |
| Return On Tangible Assets | 0.003769 | 0.008518 | 0.002166 | 0.0846 | 0.14 | 0.15 | |
| Ev To Free Cash Flow | (201.75) | (96.8) | (552.23) | 434.14 | 57.06 | 59.91 | |
| Earnings Yield | 4.11E-4 | 9.33E-4 | 2.25E-4 | 0.0136 | 0.0229 | 0.024 | |
| Intangibles To Total Assets | 0.0366 | 0.0373 | 0.0565 | 0.0581 | 0.0486 | 0.0462 | |
| Net Debt To E B I T D A | 0.87 | 3.28 | 6.64 | 2.2 | (2.05) | (1.95) | |
| Current Ratio | 6.01 | 5.81 | 3.6 | 3.51 | 3.58 | 3.4 | |
| Tangible Book Value Per Share | 8.27 | 7.09 | 5.03 | 8.35 | 15.15 | 15.91 | |
| Receivables Turnover | 8.92 | 10.79 | 6.82 | 4.72 | 5.67 | 4.98 | |
| Graham Number | 4.69 | 6.77 | 3.2 | 26.44 | 48.19 | 50.6 | |
| Shareholders Equity Per Share | 9.32 | 8.22 | 6.87 | 10.5 | 17.29 | 18.15 | |
| Debt To Equity | 1.73 | 2.24 | 2.94 | 1.93 | 0.0692 | 0.0657 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 5.77 | Revenue Per Share | Quarterly Revenue Growth 0.172 | Return On Assets |
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.